Pfizer will leverage ConcertAI’s artificial intelligence-powered analytics capabilities to gain better oncology insights.The partnership will use the AI platform to gain faster actionable insights for Pfizer‘s investigational therapies and commercialized therapeutics for treatment of solid tumors and hematologic malignancies, officials said.